Health Archive » January, 2010

Health - January, 2010

202 articles

• Cos. Pay Big To Settle Patent Fights With Rivals
• Merck Drug Liability MDL To Go To Trial: Judge
• Obama Seeks More Cash To Fight Health Care Fraud
• Calif. Court Revives Kaiser Autism Coverage Case
• Monaghan Medical To Stop Sales Of Disputed Inhaler
• 3rd Circ. Sinks Ex-Health Net Atty's Defamation Suit
• IMS Health Settles Shareholder Suits Over Merger
• Why The 3rd Circ.'s Unisys Decision Defies ERISA
• Antitrust Claims Dropped In 3M Stethoscope IP Suit
• Class Action Slams Hospital Over Unnecessary Stents
• USPTO To Update Patent Term System After Ruling
• Aventis Wins Dismissal Of $3M Fraudulent Transfer Suit
• Levaquin Plaintiffs Seek To Pry Docs From J&J's Hands
• UBS Blocks Swiss Investors' $40M FINRA Claim
• NH Can't Nab $110M Of Medical Fund: State High Court
• Enzo Settles Litigation With Founder Over Firing
• An Endangered Species: Physician-Owned Hospitals
• Generics Makers Challenge AstraZeneca In Crestor MDL
• Patent Nixed From Hologic-Ethicon Breast Biopsy Spat
• Par, Fleming Drop Spat Over Nasal Spray Patent
• NY Claims Stand In AWP Drug MDL
• House Panel Advances Inquiry Into Health Bill Deal
• FTC OKs $650M Danaher-MDS Deal With Conditions
• Subclasses Dismissed In Dentsply Negligence Case
• Flonase Antitrust Suit Withstands GSK Dismissal Bid
• The Outcome Of Overly Broad Restrictive Covenants
• Bavarian, BioMedica Call Vaccine Patent Truce
• Sex Bias Plaintiffs' Bid To Sanction Novartis Nixed
• In-House Counsel Name Favorite Litigators
• Novartis Reaches $185M Deal Over Off-Label Claims
• Teva Triumphs Over Merck In Temodar Patent Spat
• Defect Sparks Massive Nipro Needle Recall
• Long-Running Allstate Billing Action Nears Finish Line
• Ex-Assistant Manager Hits CVS With Overtime Action
• J&J, Swiss Co. End OneTouch Counterfeit Feud
• Bausch & Lomb Appeals 'ReNu' Duty To Defend Loss
• Saudi Embassy Unit Hits Aetna Over Rate Hike
• Written Description: Not Co-Extensive With Enablement
• Fed. Circ. Finds Boehringer's Mirapex Patent Valid
• PerkinElmer Patent Suit Dropped Days After It Began
• J&J Unit Wins Bid To Nix Tylenol Product Liability Suit
• NJ Ratchets Up Penalties For Medical Waste Dumping
• Cephalon Slaps Sandoz Over Generic Narcolepsy Drug
• Fed. Circ. Affirms Abbott Losses Over Test Strip Patents
• Enzo Founder Tries To Bar Annual Board Meeting
• Pfizer Wants Wyeth Merger Case Thrown Out For Good
• Diprivan Supplier Beefs Up AstraZeneca Contract Suit
• Trumpf Fights To Nix Duties On Surgical Lamps
• BioScrip Snags Critical Homecare For $343M
• FDCA And Liability For State Failure-To-Warn Claims
• Medtronic Puts $350M Down For Invatec
• Ala. AG Loses Bid To Revive $275M AWP Cases
• Fed. Circ. Deals Blow To Takeda In Prevacid Battle
• Nelson Mullins Adds Medical Malpractice Partner
• Nipro Issues Recall Of Insulin Syringes Sold In US
• Judge Advises To Keep Expert In Dentsply Case
• Flonase Indirect Buyers Survive Standing Challenge
• Sequenom To End Shareholder Suits With $45M Deal
• Court Limits Atty Contact With MDs In Ortho Evra MDL
• Consumers Push For Class Status In Digitek MDL
• Abbott Offers EU Antitrust Remedies On Solvay Deal
• Rulings Underscore Need For E-Discovery Expertise
• J&J Stent Patents Found Invalid In Boston Sci Suit
• Abbott Stops Marketing Weight Loss Drug In Europe
• As Trial Nears, Kaiser Flays Pfizer Neurontin Studies
• German Courts Weigh In On Edwards' Patent Fight
• UnitedHealth Denied Ruling In Excess Insurance Spat
• Mishcon Opens NY Office With Sheppard Mullin Attys
• Martek To Buy Supplement Maker Amerifit For $200M
• Pfizer Settles Zoloft Preemption Case
• FDA Taps Acting Director To Lead Devices Unit
• Class Decertification Stands In Pa. Neurontin Suit
• IT Employee Lodges FLSA Suit Against Kaiser
• Abbott's 'New Theories' In AWP Case Draw US' Ire
• Katten Lures Sonnenschein White Collar, Health Attys
• New DOJ Position To Oversee Discovery Initiatives
• Boston Scientific Stent Patent Suit Moved To NJ
• Tech, Energy Took Biggest Antitrust Hits Last Year
• Cordis Sues Boston Scientific Over Stent Patents
• Medical Cos. Get OK For Long Brief In Gene Patent Spat
• Tyco Settles Syringe Disposer Antitrust Suit For $33M
• SLU Hospital Escapes Guidant Defibrillator MDL
• Molina Healthcare Buys Unisys Unit For $135M
• Ala. Top Court Reverses Class Cert. In Duract Case
• Pfizer Slaps Teva With Suit Over Zyvox ANDA
• Face-Lift Patient Denied Class Status
• Protein Sciences Dropped From Vaccine Patent Spat
• Judge OKs Howmedica's Appeal Of Invalidity Ruling
• Lab Test Co. Hits Rival, Ex-Workers With Secrets Suit
• Ethicon Must Turn In Evidence In ObTape MDL
• Acacia Unit Wraps Up Medical Image Patent Suit
• Genzyme, Daiichi Try To Halt Impax's Generic Welchol
• Obama Wants To Limit Biologic Protection In Health Bill
• Abbott, Others Marketed Stents Off-Label: Suit
• J&J Unit Widens Recall Over Contamination Concerns
• Judge Refuses To Nix Bristol-Myers' Sustiva Case
• DOJ Slaps J&J Over Millions In Kickbacks To Omnicare
• Importing Drugs, Medical Devices To US From China
• Don't Nix Gene Patents, BPLA Tells Court
• Sens. Press For Insurance Antitrust Exemption Repeal
• Ambulance Co. Hit With Wage-And-Hour Class Action
• KV To Settle Claims Against Citigroup In ARS MDL
• Shareholders Fight Amgen's Stay Bid
• Judge Slams FDA Over Detained Electronic Smokes
• Apotex Wants Abbott's Meridia Patent Suit Out Of Del.
• Mass. Judge Says Faith-Based Healing Not Medicine
• AGs Slam Health Care Bill's 'Cornhusker Kickback'
• Business Associate Agreements Under HITECH Act
• Hospital Official Pleads Guilty In Bid-Rigging Probe
• Insurer Accuses Firm Of Millions In Fraudulent Billing
• Luna Wins Ch. 11 OK After Settlement With Hansen
• Mannatech Resolves Supplement Patent Case
• FTC Tells Congress To Scrap Pay-For-Delay
• US Fights DeCode Asset Sale Due To Security Risks
• Houston Hospital, Investors In Rival Settle Antitrust Spat
• Norvir Antitrust Cases Survive Abbott's Bid To Dismiss
• Rival's Claims, Not Its Condoms, Too Thin: Trojan
• Cook Stent Patent Suit Stayed For Re-Exam
• Judge Picks Merck's Discovery Plan In NuvaRing MDL
• Pharma Industry Under Antitrust Scrutiny
• Obama Backs Repealing Insurance Antitrust Exemption
• NY Stops Drug Flushing At 5 Health Care Facilities
• FDA Scolds Lilly, Bayer, Others Over Drug Ads
• Merck Discovery Bid Mooted In NuvaRing MDL
• Sonnenschein Nabs Biotech Expert From Dickstein
• EC To Monitor Pharma Patent Settlements
• National Union D&O Defense Case Stayed For Appeal
• Quidel Picks Up Diagnostic Hybrids For $130M
• Novo Nordisk, Sanofi Cap Feud Over Insulin Pen
• Contract Suit Over $435M Sale Of Dental Biz Tossed
• Judge Orders CCS 2nd-Lien Lenders Committee
• CORRECTED: SEC Ends $3B Fraud Case Against National Century Execs
• High Court Rebuffs Boston Scientific Section 271(f) Suit
• Synthes, Howmedica End Bone Device Patent Suits
• Consumer Groups, AAI Push Pay-For-Delay Ban
• Supreme Court Won't Take On Omnicef Patent Case
• Former Indevus VP Agrees To Insider Trading Deal
• LLCs Are Citizens Of Main Business State: 4th Circ.
• Pension Fund Sues To Block Novartis, Alcon Deal
• License Deal Ends IP Spat Between Caliper, BD
• FDA Halts Sybaritic Sales Of Unapproved Devices
• Pharmacies Hone Claims In Pfizer-Wyeth Merger Suit
• Suit Slams Fidelity Over Ingenix Reimbursement Fraud
• Aetna, Guardian Ousted From Neurontin Off-Label MDL
• Apotex Seeks Stay In Plavix Suit Pending USPTO Ruling
• I-Flow Wins Injunction, Damages In Pump Patent Suit
• 5th Circ. Rejects Generic Preemption Argument
• Inverness Sues Rival Over Pregnancy Test Patent
• 9th Circ. Denies Rehearing In CTI Contract Suit
• Lawson To Snap Up Healthvision For $160M
• Synthon Claims Sepracor Misled USPTO On Xyzal
• Biomet Settles Trade Secrets Suit With Ex-Distributor
• Can Antitrust Exemption Survive Health Care Reform?
• Shareholders Appeal NeuroMetrix Fraud Dismissal
• Dentsply Class Action Over Cavitron Is Back On Track
• Wyeth Scores In Patent Term Adjustment Spat With PTO
• Del. Judge Tosses 2 Seroquel Suits
• AstraZeneca, Teva Settle Heartburn Drug Patent Suits
• Abbott Coughs Up $23M To Settle Patent Fraud Claims
• Stryker To Exit Acacia Unit Medical Imaging Patent Suit
• Interpreting Oral Arguments In Ariad V. Eli Lilly
• Fla. Spinal Patient Seeks Class Cert. In ADA Suit
• FDA Warns Against Bystolic For Heart Patients
• TLC Vision Ch. 11 Plan Leaves Shareholders In Dust
• EU Launches Antitrust Probe Over Lundbeck Drug
• FDA To Look At Risks Of J&J, Amgen Anemia Drugs
• GSK Liability Suit Remanded To Ill. State Court
• KV Action Over Metoprolol Preempted: Judge
• 8th Circ. Ships 3 Prempro Suits Back To State Court
• Cephalon Deals Went Beyond Provigil: Direct Buyers
• 9th Circ. Upholds Tyco Healthcare's Antitrust Win
• 7th Circ. Hands U. Of Wis. Victory In Licensing Fight
• Orrick Lands Hughes Hubbard Antitrust, Health Atty
• Jones Day Nabs M&A Partner From Baker McKenzie
• Governance Implications Of Health Care Reform
• FDA To Study Drug Safety For Pregnant Women, Fetuses
• Cephalon Sues Watson Over Generic Nuvigil
• Judge Certifies Class In Home Care Insurance Fight
• Former World Health Execs Settle Civil Fraud Claims
• Novartis, Roxane Drop Most Famvir Patent Claims
• Trade Secrets Suit V. Allparts Medical Tossed
• Allergan Can Demand Jury In Sandoz IP Fight: Judge
• 8th Circ. Denies W. Va. Baycol Plaintiffs Bid To Refile
• Baptist Health, Blue Cross Off Hook In Antitrust Suit
• Fed. Circ. Revives Philips Defibrillator Patent Suit
• AMO Wipes Out Contact Lens Solution Class Action
• Novartis Snaps Up Corthera For $120M
• Pa. Appeals Court Upholds $1.5M Provera Verdict
• Aperio, Hamamatsu Look To Settle Scanner Patent Feud
• Medicines Co. Hits Teva With New Angiomax Suits
• Gene Patents Don't Violate Constitution: USPTO
• Chubb Faces Suit Involving 'Dr. Phil' Supplement
• Spectranetics To Pay $5M Over Unapproved Lasers
• Centocor Seeks Continuing Damages Over Humira
• SOX Gives Whistleblowers De Novo Review: 4th Circ.
• Generics Makers Infringe Lilly's Strattera Patent: Judge
• Paratek Sues USPTO Over Drug Patent Term
• Rejecting 'Bundling' Claims In The 9th Circ.
• Lexington Need Not Cover B&L's ReNu Claims: Judge
• Novartis Snaps Up Nestle's Alcon Share For $28.1B
• Health Legislation To Watch In 2010
• Health Cases To Watch In 2010